Table 2.
Baseline characteristics of the 204 patients
| Variable | All patients (n = 204) |
| Sex (male/female) | 174/30 |
| Age, yr | 52.0 ± 11.4 |
| BMI, kg/m2 | 23.2 ± 3.6 |
| Cause of hepatitis (Hepatitis B/C/Others) | 174/2/28 |
| PH (yes/no) | 48/156 |
| Liver cirrhosis (yes/no) | 120/84 |
| P grade (A/B) | 187/17 |
| BCLC stage (0 or A/B/C) | 113/62/29 |
| PA, mg/L | 198.5 (149.3-238.0) |
| ALB, g/L | 41.0 ± 4.7 |
| TBIL, μmol/L | 13.3 (9.7-18.3) |
| PT, s | 13.7 (13.0-14.5) |
| ALT, U/L | 36.0 (26.3-56.0) |
| AFP, μg/L | 76.4 (9.02-1082.5) |
| INR | 1.0 (0.98-1.1) |
| PLT, × 109/L | 135.0 (99.8-181.0) |
| Number of tumors (1/2/≥3) | 161/27/16 |
| Tumor size, cm | 4.0 (3.0-6.5) |
| PVTT (yes/no) | 30/174 |
| Capsule formation (yes/no) | 27/177 |
| Differentiation (well/poor) | 81/123 |
| Surgical bleeding, mL | 300 (180-575) |
| Blood transfusion (yes/no) | 68/136 |
| Type of liver resection (minor/major) | 159/45 |
| Intraoperative radiotherapy and/or chemotherapy (yes/no) | 148/56 |
| ALBI grade (1/2/3) | 136/66/2 |
| MCP grade (1/2/3) | 110/52/42 |
| Overall survival time, mo | 44.0 (22.0-74.0) |
| Recurrence-free survival time, mo | 22.0 (5.0-45.0) |
BMI: Body mass index; PH: Portal hypertension; C-P: Child-Pugh; BCLC: Barcelona Clinic Liver Cancer; PVTT: Portal vein tumor thrombus; MCP: Modified Child-Pugh; ALBI: Albumin-bilirubin. Type of liver resection: Minor, ≤ 3 liver segments; major, ≥ 4 liver segments. Intraoperative radiotherapy: Implanted with radiation particles I125 or I131. Intraoperative chemotherapy: Implanted with a chemotherapy pump.